|
C7ORF64 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.73316916374233E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.25388629771351E-13 |
| Normal-vs-Stage2 |
1.382020E-03 |
| Normal-vs-Stage3 |
5.47499823255748E-11 |
| Normal-vs-Stage4 |
1.18179910302274E-11 |
| Stage1-vs-Stage2 |
1.918010E-01 |
| Stage1-vs-Stage3 |
1.730200E-01 |
| Stage1-vs-Stage4 |
1.509640E-02 |
| Stage2-vs-Stage3 |
5.938500E-02 |
| Stage2-vs-Stage4 |
8.796600E-03 |
| Stage3-vs-Stage4 |
2.543800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.65973959207622E-14 |
| Normal-vs-AfricanAmerican |
4.15230000000433E-05 |
| Normal-vs-Asian |
5.16429999986023E-07 |
| Caucasian-vs-AfricanAmerican |
8.511200E-01 |
| Caucasian-vs-Asian |
5.692400E-01 |
| AfricanAmerican-vs-Asian |
8.376800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.49580348107747E-11 |
| Normal-vs-Female |
3.28648219749539E-12 |
| Male-vs-Female |
3.749600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.14730455638801E-11 |
| Normal-vs-Age(41-60Yrs) |
7.68179964083515E-11 |
| Normal-vs-Age(61-80Yrs) |
2.87559998035647E-09 |
| Normal-vs-Age(81-100Yrs) |
1.159970E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.550800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.145400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.570970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.553400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.947430E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.335200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.876850E-03 |
| Classical-VS-Follicular |
2.017800E-01 |
| Classical-VS-Other |
4.364600E-01 |
| Classical-VS-Normal |
2.04825045813095E-12 |
| Tall-VS-Follicular |
7.166300E-04 |
| Tall-VS-Other |
5.767000E-01 |
| Tall-VS-Normal |
4.89142060189351E-12 |
| Follicular-VS-Other |
3.190800E-01 |
| Follicular-VS-Normal |
1.97435000000024E-05 |
| Other-VS-Normal |
1.819720E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.90620030449918E-10 |
| Normal-vs-N1 |
1.05200004263395E-09 |
| N0-vs-N1 |
6.414000E-02 |
|
|
